FORT WASHINGTON, Pa.–NEWS–Age coupled with the presence of cytogenetic abnormalities are key determinants when making treatment decisions for patients with ALL as stated by Daniel J. DeAngelo, MD, at a recent NCCN Congress.
DUBLIN–NEWS–Research and Markets (http://www.researchandmarkets.com/research/04e549/market_for_drug_de) has announced the addition of the “Market for Drug Delivery Systems in the US” report to their offering. The demand for drug delivery systems in the US is visualized to grow and reach over $135 billion by come 2015, as a result of growth of almost 9% every year since...
DUBLIN–NEWS–Research and Markets (http://www.researchandmarkets.com/research/6f868c/scar_pipeline_re) has announced the addition of Global Markets Direct’s new report “Scar – Pipeline Review, H2 2011″ to their offering. ‘Scar – Pipeline Review, H2 2011′, provides an overview of the Scar therapeutic pipeline. This report provides information on the therapeutic development for Scar, complete with latest updates, and special features...
PARIS–NEWS–Nanobiotix, ein Entwicklungsunternehmen für neuartige Tumor-Nanotherapeutika, gab heute bekannt, dass sein Leitwirkstoff NBTXR3 die formelle Zulassung der französischen Arzneimittelbehörde AFSSAPS1für die erste klinische Studie2 erhalten hat. 27 Patienten mit der Diagnose Weichteilsarkom werden an der Studie Phase I teilnehmen und NBTXR3 als Injektion in den Tumor sowie eine Strahlentherapie vor der Operation (Erstbehandlung) erhalten...
LIMA, Ohio–NEWS–KeyBridge’s Dave Morrisey to Provide Insight on Turning Patient-Pay Accounts into Revenue During Healthcare Billing Management Association Annual Conference
DUBLIN–NEWS–Research and Markets (http://www.researchandmarkets.com/research/af6e73/lip_and_oral_cavit) has announced the addition of GlobalData ‘s new report “Lip and Oral Cavity Cancer Global Clinical Trials Review, Q2, 2011″ to their offering. Lip and Oral Cavity Cancer Global Clinical Trials Review, Q2, 2011 provides data on the Lip and Oral Cavity Cancer clinical trial scenario. This report provides elemental...
SAN FRANCISCO & PALO ALTO, Calif.–NEWS–Intersect ENT, Inc., an innovator in treatment solutions for ear, nose and throat clinicians and patients, today reported data from its pivotal clinical trial, ADVANCE II. ADVANCE II is a prospective, randomized, controlled, double-blind, multicenter trial showing that use of the Propel™ mometasone furoate implant significantly improves outcomes for...
WASHINGTON–NEWS–A small pilot study led by a Department of Veterans Affairs (VA) researcher found that a nasal insulin spray improved memory, thinking skills, and functional ability in people with mild cognitive impairment and Alzheimer’s disease. Currently, there are no effective treatments to delay or prevent Alzheimer’s. “This research builds on several years of preliminary...
DUBLIN–NEWS–Research and Markets (http://www.researchandmarkets.com/research/113ab6/varicose_veins_glo) has announced the addition of GlobalData’s new report “Varicose Veins Global Clinical Trials Review, Q2, 2011″ to their offering. Varicose Veins Global Clinical Trials Review, Q2, 2011″ provides data on the Varicose Veins clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Varicose...
LOS ANGELES–NEWS–WestPark Capital, Inc., the Los Angeles-based international investment banking company, has hired Robert Keyser and R. Douglas Armstrong, Ph.D. to head up their new Life Sciences Division. The new division will be called Tekesta Capital Partners. The division’s focus and specialization will be in assisting small and micro-cap public companies with capital strategies...